Skip to main content

Table 1 Demographic and Clinical Patient Characteristics (n = 30)

From: Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication

Age, mean ± SD, years 37.5 ± 9.7
Sex, n (%), female/male 13(43.3)/17(56.7)
Duration of illness, mean ± SD, years
PANSS score at baseline, mean ± SD
8.7 ± 6.7
 Total score 59.7 ± 16.5
  Positive symptoms 12.1 ± 5.1
  Negative symptoms 17.0 ± 7.1
  General psychopathology 30.6 ± 8.1
GAF score at baseline, mean ± SD 56.7 ± 16.4
  1. PANSS = Positive and Negative Syndrome Scale; GAF = Global Assessment of Functioning Scale